Messinger Michael

Avg. Two Year Performance

(22%) Avg. Purchase Return

(11%) Compound

No sale track record

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	123%	30%	37%	60%	(22%)
Purchase Success Rate	1 of 2	1 of 2	1 of 2	2 of 2	0 of 2
Average Sale Return	--	--	--	--	--
Sale Success Rate	--	--	--	--	--

Contrafect Corp

Drugs » Biotechnology

Chief Financial Officer:

Holdings: 19.09K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--